Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care |
| Investeringsfocus | Equity, World, Health Care, Social/Environmental |
| Fondsgrootte | EUR 14 m |
| Totale kostenratio (TER) | 0.18% p.a. |
| Replicatie | Fysiek (Volledige replicatie) |
| Juridische structuur | ETF |
| Strategierisico | Langdurig |
| Duurzaamheid | Yes |
| Valuta van het fonds | USD |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | 16.27% |
| Startdatum/Noteringsdatum | 12 April 2023 |
| Distributiebeleid | Accumulerend |
| Distributiefrequentie | - |
| Vestigingsplaats van het fonds | Ireland |
| Fondsaanbieder | Invesco |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | BNY Mellon Fund Services (Ireland) Designated Activity Company |
| Beleggingsadviseur | Invesco Capital Management LLC |
| Bewaarbank | BNY Mellon Trust Company (Ireland) Limited |
| Revisiebedrijf | PricewaterhouseCoopers |
| Einde belastingjaar | 31 December |
| Vertegenwoordiger van Zwitserland | BNP Paribas, Paris, succursale de Zurich |
| Zwitserse uitbetalende instantie | BNP Paribas, Paris, succursale de Zurich |
| Duitsland | Unknown |
| Zwitserland | ESTV Reporting |
| Oostenrijk | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Totale rendementsindex |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | Yes |
| Tegenpartij die effecten uitleent |
| Eli Lilly & Co | 14.20% |
| AbbVie | 10.10% |
| AstraZeneca | 5.20% |
| Roche Holding | 4.80% |
| Abbott Laboratories | 4.80% |
| Merck & Co | 4.60% |
| Novartis | 3.70% |
| Gilead Sciences | 3.40% |
| Thermo Fisher Scientific | 3.20% |
| Amgen | 3.00% |
| United States | 67.70% |
| Switzerland | 10.40% |
| United Kingdom | 6.10% |
| Japan | 4.50% |
| Other | 11.30% |
| Health Care | 97.60% |
| Consumer Discretionary | 1.50% |
| Other | 0.90% |
| YTD | +2.68% |
| 1 month | +1.41% |
| 3 months | +1.77% |
| 6 months | +13.44% |
| 1 year | -0.86% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | +16.19% |
| 2025 | +2.01% |
| 2024 | +8.30% |
| 2023 | - |
| 2022 | - |
| Volatility 1 year | 16.27% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | -0.10 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -19.93% |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -21.52% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | WH2E | - - | - - | - |
| Borsa Italiana | EUR | WDHE | WDHE IM WHCEINE | WDHE.MI I2PZINAV.DE | Societe Generale |
| London Stock Exchange | GBX | WHCG | WHCG LN WHCEINS | WHCG.L I2P0INAV.DE | Societe Generale |
| London Stock Exchange | USD | WHCE | WHCE LN WHCEIN | WHCE.L I2P1INAV.DE | Societe Generale |
| SIX Swiss Exchange | USD | WHCE | WHCE SW WHCEIN | WHCE.S I2P1INAV.DE | Societe Generale |
| XETRA | EUR | WH2E | WH2E GY WHCEINE | WH2E.DE I2PZINAV.DE | Societe Generale |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) | 532 | 0.18% p.a. | Distributing | Full replication |